AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks 14 day Free Trial

LTR PHARMA LIMITED (LTP)


AI Coverage Rating: Active

ASX AI Signals has generated 4 signal for LTP during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest LTP Signals

09/06/2026BUY
08/06/2026BUY
07/06/2026BUY

LTP Share Price

Current Price$0.575
52 Week High$0.735
52 Week Low:$0.285
Trading at (% of 52 Week High) 78.23%


Volume 154312
20 Day Avg 739390
Relative Volume 20.9%


Business Overview

LTR Pharma Limited (ASX: LTP) is an Australian pharmaceutical company specializing in the development and commercialization of novel medicines for the treatment of respiratory and inflammatory diseases. The company focuses on advancing its product pipeline through research, clinical trials, and strategic partnerships.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for LTR PHARMA LIMITED at the current price of 0.4650 is supported by positive momentum indicators and potential sector growth. However, moderate liquidity and volatility concerns temper the confidence level.

Latest  LTR PHARMA LIMITED(LTP)   News

Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial